---
audienceLevel: patient
cancerTypes:
- breast
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Palbociclib - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/palbociclib
version: v1
---

# Palbociclib - NCI

# Palbociclib

Placeholder slot

(PAL-boh-SY-klib)

Palbociclib works by blocking the activity of proteins called CDK4 and CDK6 that control how fast cells grow. Blocking these proteins may slow or stop the growth of cancer cells. Palbociclib is a type of targeted therapy drug called a kinase inhibitor. It is a small-molecule drug (a drug that can enter cells easily).

US Brand Name(s)

Ibrance

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0e6412f-50b4-4fd4-9364-62818d121a07&audience=consumer)

## Use in Cancer

Palbociclib
is approved
to be used with other [drugs](/Common/PopUps/popDefinition.aspx?id=348921&version=Patient&language=English) to treat:

- **[Breast cancer](/Common/PopUps/popDefinition.aspx?id=444971&version=Patient&language=English)** that is [hormone receptor positive](/Common/PopUps/popDefinition.aspx?id=788029&version=Patient&language=English) (HR+) and [HER2 negative](/Common/PopUps/popDefinition.aspx?id=774531&version=Patient&language=English) (HER2-) and has spread. It is used:
- with [fulvestrant](/Common/PopUps/popDefinition.aspx?id=306498&version=Patient&language=English) in adults whose cancer has gotten worse after treatment with [hormone therapy](/Common/PopUps/popDefinition.aspx?id=45110&version=Patient&language=English)
- with an [aromatase inhibitor](/Common/PopUps/popDefinition.aspx?id=44232&version=Patient&language=English) in [postmenopausal](/Common/PopUps/popDefinition.aspx?id=45269&version=Patient&language=English) women and in men who have not been treated with hormone therapy

Palbociclib
is also being studied in the treatment of other types of
cancer.

## More About Palbociclib

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/454586) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Palbociclib](https://medlineplus.gov/druginfo/meds/a615013.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

[Experimental Medulloblastoma Treatment Gets a Boost with Nanoparticles](https://www.cancer.gov/news-events/cancer-currents-blog/2022/medulloblastoma-nanoparticle-palbociclib-sapanisertib)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Palbociclib](https://www.cancer.gov/research/participate/clinical-trials/intervention/C49176) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
